A Case of Sarcoidosis Associated With Anti-Tumor Necrosis Factor Treatment
Sarcoidosis is a systemic chronic granulomatous disease of unknown etiology. It predominantly involves the lungs but can affect many organs or tissues in the body, such as the lymphatic system, skin, eyes, and liver. Typical histopathological lesions are noncaseating granulomas in the affected organ...
Saved in:
Main Authors: | Ayse Baha MD (Author), Cigdem Hanazay MD (Author), Nurdan Kokturk MD (Author), Haluk Turktas MD (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2015-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
by: José Luis Callejas-Rubio, et al.
Published: (2008) -
Ulcerative necrobiosis lipoidica in the setting of anti-tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis
by: Jennifer Albus Fehlman, MD, et al.
Published: (2017) -
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021) -
Clinical features of tumor necrosis factor-α-inhibitor induced chilblain lupus: A case series
by: Nadine Shabeeb, MD, MPH, et al.
Published: (2021) -
Successful treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis with tofacitinib: Report of case
by: Yixin Ally Wang, BA, et al.
Published: (2020)